Marketandmarket Research

  Nearly 9.6 million people died of cancer worldwide in 2018, according to a data given by World Health Organization. The number of cardiovascular diseases has increased worldwide and thus thrusting the nuclear medicine market. The market is expected to grow at an annual growth rate of almost 10% in the next 10 to 15 years. By 2021, the global nuclear medicine market is estimated to be worth more than 8 billion U.S. dollars, and is expected to grow at a compound annual growth rate of approximately 10% during the forecast period from 2022-2030. The increase in the incidence of cancer is one of the main factors that are expected to promote the development of the nuclear medicine market. For example, according to the World Health Organization, approximately 9.6 million people died of cancer worldwide in 2018; in addition, the increasing prevalence of cardiovascular diseases is driving the growth of the nuclear medicine market. For example, according to the World Health Organization, card

  The number of tests conducted in US was almost 1.5 million for 2013, and the number grew tremendously for 2014 i.e., 422 million worldwide; according to the data given by International Diabetes Federation (IDF). This ever-increasing number is giving a boost to in vitro diagnostic quality control market and expected to do so in the upcoming decade as well. The global in vitro diagnostic quality control market is estimated to be worth nearly one billion US dollars and is expected to grow at a compound annual growth rate of 5% during the forecast period from 2022-2030. The presence of more and more accredited clinical laboratories and supporting regulatory agencies around the world is expected to be a key factor driving market growth. Due to the high incidence of diabetes, cardiovascular disease (CVD) and infectious diseases, diagnostic laboratories are developing rapidly. Many public and private laboratories are undergoing laboratory certification procedures to comply with industry st

  The number of cancer cases have outgrown in the past and the treatments to them have increased in number. This number is expected to increase in the future as well. The pemetrexed diacid market is expected to experience an annual growth rate of almost 10% in the near future or so. The market value of pemetrexed diacid in 2020 is 5 billion U.S. dollars and is expected to reach 10 billion U.S. dollars in 2030. The North American market is expected to participate in the pemetrexed acid market . This status can be attributed to the large existing pemetrexed acid user base in the region. Therefore, North America is considered the most important player in the market. Other regions, such as the Asia-Pacific region, may expand in the next few years. The latest survey of the global pemetrexed acid market covers various industry organizations from different regions and generates more than 100 pages of reports. The study seamlessly integrates qualitative and quantitative information, focusing o

  Cancer was the leading reason of death in 2018, according to the World Health Organization (WHO). And the data is ever-increasing. The surge in active cases of cancer and HIV worldwide, the real-time PCR (qPCR) and digital PCR (dPCR) market is expected to grow at an annual growth rate of almost 9% in the next 10 to 15 years. In 2021, the global market for real-time PCR (qPCR) and digital PCR (dPCR) is estimated to be approximately US$3 billion. It is expected to grow at a compound annual growth rate of 9% during the forecast period from 2022-2030. The epidemiology of target diseases and rapid technological progress, such as the development of high-throughput systems, qPCR systems, and dPCR systems, can become an important driving force for growth. According to the World Health Organization (WHO), cancer was the leading cause of death in 2018, and 9.6 million people worldwide died of cancer. The World Health Organization (WHO) estimates that 36.9 million people were infected with HIV

  According to a recent study conducted by Kenneth Research, the R&D pipeline drugs is getting a worldwide surge in the market. The protein labelling has a vast role in proteomics and many biotechnological tools which are working for the betterment of human kind effortlessly. The protein label market is expected to experience good growth in the next decade of almost 8% CAGR.   The global protein label market value is expected to reach US$2 billion in 2020, and it is expected to grow at a compound annual growth rate of 8% between 2022 and 2030. Rising R&D costs in protein research, protein analysis meets the demand of Protein labelling technology. The increase in R&D costs has expanded the application scope of proteomics in mass spectrometry, protein matrix and biochemistry, thereby benefiting proteomics. In addition, improved mass spectrometry and two-cell extraction have led to the development of protein procedures and an increase in organic sales on the market. With the

  According to a recent study conducted by Kenneth Research, the R&D pipeline drugs is getting a worldwide surge in the market. The protein labelling has a vast role in proteomics and many biotechnological tools which are working for the betterment of human kind effortlessly. The protein label market is expected to experience good growth in the next decade of almost 8% CAGR.   The global protein label market value is expected to reach US$2 billion in 2020, and it is expected to grow at a compound annual growth rate of 8% between 2022 and 2030. Rising R&D costs in protein research, protein analysis meets the demand of Protein labelling technology. The increase in R&D costs has expanded the application scope of proteomics in mass spectrometry, protein matrix and biochemistry, thereby benefiting proteomics. In addition, improved mass spectrometry and two-cell extraction have led to the development of protein procedures and an increase in organic sales on the market. With the

  The need for effective treatment for various neurological disorders has increased exponentially in the last decade. The neuroprosthetics market is still growing rapidly which boosts the future market as well. The market is expected to grow at an annual growth rate of almost 15% in the next decade. By the end of 2021, the neuroprosthesis market is expected to exceed USD 6 billion, and is expected to grow at a compound annual growth rate of 15% during the period 2022-2030. The high prevalence of diseases such as Parkinson’s disease, epilepsy, hearing, eyes, musculoskeletal system, Alzheimer’s disease and major depression are the main reasons. disease. Prosthetics market. In addition, R&D investment in the production of new equipment and products through innovative computer-aided technology (BCI) is expected to increase to develop effective neurological disorders, equipment, and industry treatment plans. During the forecast period, the increasing use of bioenergy self-loading impla

  According to a study in the Journal of the American College of Radiology (JACR), compared with 2019, the total imaging volume was reduced by 28% during the seven weeks during the COVID-19 pandemic. The optical imaging system market is supposed to grow at an annual growth rate of almost 15% worldwide. It is estimated that by 2021, the global market for optical imaging systems will exceed US$2 billion. It is expected that the increasing use of optical imaging in clinical and clinical trials in the pharmaceutical and biotechnology fields, as well as the increasing influence of advanced technologies, will drive growth. diagnosis. And treatment. It plays a very important role in preclinical research, helping to continuously monitor disease progression and molecular effects in animal models, thereby accelerating the development of this field. Due to the increasing use of these technologies in the pharmaceutical and biotechnology industries as well as medical diagnosis and treatment, optic

  The organ-on-chip market is expected to grow with an annual rate of almost 40% for the next 10 to 15 years. The device is very much in demand nowadays as the tendency and possibility to control things has increased with time. And this demand will boost the market globally. The organ chip market is expected to exceed 10 million U.S. dollars in 2021, and it is expected to reach 170 million U.S. dollars in 2023, with a compound annual growth rate of over 40% from 2022 to 2030. OOC) is a microfluidic cell culture device that was developed using a microchip manufacturing method that contains continuously perfused chambers that are inhabited by living cells and are used to simulate physiological functions at the organ and tissue level. The chip develops a narrow channel for blood and air flow in the lungs, intestines, liver, heart and other organs. Such equipment produces multi-level tissue and organ functions, which is not feasible for traditional 2D and 3D culture systems. Organ chips p

  Synthetic biology is used for various branches to biotechnology such as Biochemistry, medicine, food crop improvement as well as green energy. The market is very helpful for the new-age problems such as renewability and sustainability. The market is expected to get a boost of almost 10% CAGR in the next 10 to 15 years. By the end of 2022, the synthetic biology market will exceed $15 billion, and the compound annual growth rate between 2022 and 2030 will exceed 10%. Biological product. The system is called synthetic biology or engineering biology. This is done to develop genetically modified organisms so that they can perform new preferred functions, thereby improving the performance of biological systems. Synthetic biology is a revolutionary new method of biological science that applies engineering principles to biology to manufacture new biological equipment, systems and components. Synthetic biology has recently entered the commercial market and is in its infancy. Consumer product

  It is estimated that the new cancer confirmed cases worldwide would go up to 21.7 million by 2030, according to IARC. This number is sufficient to understand that the market of virus filtration is also going to get a thrust in the near future i.e., 10 to 15 years with an annual growth rate of almost 8% CAGR. The global virus leak market size in 2021 is estimated to be around US$3 billion. The increasing prevalence of chronic diseases is one of the main factors contributing to growth. The increasing prevalence of chronic diseases such as cancer, diabetes and autoimmune diseases is expected to drive the demand for biologics. According to data from the International Agency for Research on Cancer, there were approximately 14.1 million newly diagnosed cancer cases worldwide in 2012, and this number is expected to reach 21.7 million by 2030, thereby boosting demand. Virus filtering products for R&D and manufacturing applications. Compliance with regulatory frameworks for drug developm

  In a recent study carried out by Kenneth Research, the breastfeeding alternatives are very easily available in the market. These alternatives are very easy to use. People are now aware of the benefits and awareness of breastfeeding as well. This leads to the strengthening of the breast pump market in present as well as in future with a CAGR of almost 12%. In 2022, the global breast pump market is expected to exceed USD 3 billion and grow at a compound annual growth rate (CAGR) of approximately 12% between 2022 and 20308. Insurance companies underwrite breastfeeding promotional equipment and services, namely breast pumps and breastfeeding consultations, patients do not need to pay any fees, and the demand for national products increases. Due to strong consumer demand, manufacturers and retailers in the country are struggling to maintain inventory. Although the benefits provided by health plans may vary due to the lack of specificity of the law, end users are expected to obtain high p

  By 2040, the number of new cancer cases every year is expected to increase up to 27.5 million, according to a data released by International Agency for Research on Cancer (IARC). This boosts the cryotherapy market and is expected to continue to do so in the next 10 to 15 years. The market is expected to grow at an annual rate of almost 12% globally. The global cryotherapy market is likely to expand with a revenue of more than USD 4 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of ~12% from 2022 to 2030. Cryotherapy, sometimes called cryotherapy, is a minimally invasive treatment that involves the use of extremely cold temperatures to destroy diseased tissue. Cryotherapy is widely used to treat various chronic diseases such as cancer, arthritis, pain and skin diseases such as warts, skin tags and dark spots. Compared with traditional surgery, cryosurgery has many advantages, including smaller incisions, shorter hospital stays, faster wound healing,

  Approximately 60% of the surgical operations are performed on 45 or above aged population, according to CDC. And it is estimated by UN Report of 2019, almost 16% of the world’s population is going to be 65 years or above. The increase in elderly population and increase in the number of accidents is the main cause for the boost of surgical equipment market in the near future i.e., 10 to 15 years. By the end of 2021, the global surgical equipment market is expected to be worth more than 10 billion U.S. dollars, and is expected to grow at a compound annual growth rate (CAGR) of approximately 11% from 2022 to 2030. The demand for surgeons, the rising cost of medical care, the increase in the elderly population and the increase in the number of operations are the key factors that are expected to drive market growth during the forecast period. Comparative studies on the long-term costs of medication and surgery indicate that early surgery is considered more cost-effective than continuous